Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENC1018 in moderate-to-severe active ulcerative colitis
NCT07062185Not yet recruiting
- Sponsor
- Tangdu Hospital
- Start
- Jul 2025
- Primary completion
- Aug 2025
- Modality
- Small Molecules
01
Overview
Open-label, single-arm trial of ENC1018 in ulcerative colitis (UC), sponsored by Tangdu Hospital. Primary endpoints: Adverse events (AE) and Serious Adverse Events (SAE), Tmax of ENC1018 and its major metabolites and 2 more. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
ENC1018
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT07062185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07062185.